RE:RE:DTC is a great planHe must have said 1+1=3 or more a half dozen times and accretion meaning incremental growth. So once patients are referred into the program they can receive multiple tests.
So large employers will refer their employees into this program those that are negative may get an annual test follow up, those that show positive will be in the system and could see multiple tests.
The question is how do large employers, associations, counties etc. make referrals into this program. I think that was what Noel was getting at. How easy is it for the average consumer, association, employer etc to get into these clinics for the initial testing. What's the process. Visit the website, get a referral, head to the clinic or does a mobile blood draw happen. Was expecting a lot more details on April 1.
davewho wrote: If I understand what James was trying to get across is that Care Oncology will give needed credibility to Aristotle. Its not easy to market a new test without some Oncology professionals being part and parcel to the program. Hoping this shift in direction and the acquisition will drive us forward.
Yes I agree the QR's seem to be a problem for Szls which needs to be fixed.